Literature DB >> 6279272

Intestinal mucinous substances in gastric intestinal metaplasia and carcinoma studied by immunofluorescence.

J Ma, W G De Boer, J Nayman.   

Abstract

Immunofluorescent studies using specific antisera against intestinal mucins revealed small intestinal mucin antigen (SIMA) and large intestinal mucin antigen (LIMA) in areas of intestinal metaplasia of the stomach. In 25 gastric carcinomas studied, both these antigens were detected in seven carcinomas, SIMA only was present in four and LIMA in only four cases; the antigens could not be detected in ten of the carcinomas. In 21 of the 25 gastric operation specimens, including the 15 carcinomas positive for intestinal mucin antigens, there was evidence of chronic gastritis and intestinal metaplasia. These immunohistologic observations confirm the results of recent histochemical studies that both small and large intestinal type mucins are present in intestinal metaplasia and gastric carcinomas. Our findings provide further evidence that at least a proportion of gastric carcinomas may supervene on intestinal metaplasia. The absence of one or both antigens in gastric carcinomas may indicate stages of dedifferentiation or alternatively differences in histogenesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279272     DOI: 10.1002/1097-0142(19820415)49:8<1664::aid-cncr2820490822>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Intestinal metaplasia in endoscopic biopsy specimens of gastric mucosa.

Authors:  G A Rothery; D W Day
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

2.  Widespread expression of intestinal markers in gastric carcinoma: a light and electron microscopic study using BD-5 monoclonal antibody.

Authors:  R Fiocca; L Villani; P Tenti; M Cornaggia; G Finzi; C Capella; M Prat; G Bussolati; E Solcia
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

3.  Clinicopathologic features and prognosis analysis of mucinous gastric carcinoma.

Authors:  Chunming Yin; Deming Li; Zhe Sun; Ting Zhang; Yan Xu; Zhenning Wang; Huimian Xu
Journal:  Med Oncol       Date:  2011-02-05       Impact factor: 3.064

4.  Trefoil Factor 3 (TFF3) Is Regulated by Food Intake, Improves Glucose Tolerance and Induces Mucinous Metaplasia.

Authors:  Hongfei Ge; Jonitha Gardner; Xiaosu Wu; Ingrid Rulifson; Jinghong Wang; Yumei Xiong; Jingjing Ye; Edward Belouski; Ping Cao; Jie Tang; Ki Jeong Lee; Suzanne Coberly; Xinle Wu; Jamila Gupte; Lynn Miao; Li Yang; Natalie Nguyen; Bei Shan; Wen-Chen Yeh; Murielle M Véniant; Yang Li; Helene Baribault
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

5.  Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215).

Authors:  R H Whitehead; G P Young; P S Bhathal
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

6.  Mucin immunohistochemistry of the columnar epithelium of the oesophagus (Barrett's oesophagus).

Authors:  V Duchatelle; F Potet; J Bara; J Ma; D Goldfain
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  Inappropriate mucin production in endodermal carcinoma--one point of view.

Authors:  J Nayman; W G De Boer; J Ma
Journal:  Jpn J Surg       Date:  1983-07

Review 8.  Toxicity and fetotoxicity of TCDD, TCDF and PCB isomers in rhesus macaques (Macaca mulatta).

Authors:  W P McNulty
Journal:  Environ Health Perspect       Date:  1985-05       Impact factor: 9.031

9.  Prognosis of early mucinous gastric carcinoma.

Authors:  Seong Yeob Ryu; Ho Gun Kim; Jae Hyuk Lee; Dong Yi Kim
Journal:  Ann Surg Treat Res       Date:  2014-06-24       Impact factor: 1.859

10.  Clinicopathological characteristics and outcomes in stage I-III mucinous gastric adenocarcinoma: a retrospective study at a single medical center.

Authors:  Jun-Te Hsu; Chen-Wei Wang; Puo-Hsien Le; Ren-Chin Wu; Tsung-Hsing Chen; Kun-Chun Chiang; Chun-Jung Lin; Ta-Sen Yeh
Journal:  World J Surg Oncol       Date:  2016-04-26       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.